|
Volumn 22, Issue 12, 2012, Pages 4033-4037
|
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors
a a a a a a a a a a a a a a a a a a a a
a
BIOGEN
(United States)
|
Author keywords
Aurora kinase; Cell cycle arrest; Cyclin dependent kinase; Cytotoxicity; Pyrrolopyrimidine
|
Indexed keywords
AURORA KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ARTICLE;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
IC 50;
IN VITRO STUDY;
STRUCTURE ACTIVITY RELATION;
ANTINEOPLASTIC AGENTS;
BINDING SITES;
CDC2 PROTEIN KINASE;
CELL CYCLE CHECKPOINTS;
CELL LINE;
CYCLIN-DEPENDENT KINASE 2;
DRUG DESIGN;
HUMANS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PROTEIN BINDING;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
PYRIMIDINES;
PYRROLES;
STRUCTURAL HOMOLOGY, PROTEIN;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84861578184
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.04.085 Document Type: Article |
Times cited : (25)
|
References (9)
|